Vimarsana
Biggest News Aggregation in the World

Page 13 - Abbott Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abbott Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abbott Diagnostics Today - Breaking & Trending Today

Evaluation of multiple micronutrient supplementation and medium-quantity lipid-based nutrient supplementation in pregnancy on child development in rural Niger: A secondary analysis of a cluster randomized controlled trial - Vimarsana News

Evaluation of multiple micronutrient supplementation and medium-quantity lipid-based nutrient supplementation in pregnancy on child development in rural Niger: A secondary analysis of a cluster randomized controlled trial

Christopher R. Sudfeld and colleagues evaluate the benefit of multiple micronutrient supplementation and medium‐quantity lipid‐based nutrient supplementation in pregnancy on child development in rural Niger.

Source: plos.org
At-Home Rapid COVID Tests May Expire Sooner Than You Think - Vimarsana News

At-Home Rapid COVID Tests May Expire Sooner Than You Think

COVID test kits have a limited shelf life. What happens if you use one past its date? Here's what to know before you swab.

POISE-3 Backs Wider Use of TXA in Noncardiac Surgery - Vimarsana News

POISE-3 Backs Wider Use of TXA in Noncardiac Surgery

The antifibrinolytic agent significantly reduced the risk for bleeding in a wide array of major noncardiac surgeries, suggesting an expanded role for TXA.

Cannon Quality Group Announces Expansion into IVD and Pharma Industries - Vimarsana News

Cannon Quality Group Announces Expansion into IVD and Pharma Industries

/PRNewswire/ -- Cannon Quality Group, a leading Bay Area provider of Quality Management System services to the medical device, Medtech, life sciences, and...

Adcock Ingram's flagship cold and flu brands boom after Omicron - Vimarsana News

Adcock Ingram's flagship cold and flu brands boom after Omicron

A better exchange rate and an improved manufacturing output were among underlying positive factors impacting the interim results of pharmaceutical manufacturer Adcock Ingram.

Source: news24.com